162 related articles for article (PubMed ID: 8536781)
1. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
Zorzos J; Zizi A; Bakiras A; Pectasidis D; Skarlos DV; Zorzos H; Elemenoglou J; Likourinas M
Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
[TBL] [Abstract][Full Text] [Related]
4. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
[TBL] [Abstract][Full Text] [Related]
5. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
Pocock RD; Ibrahim SK; Sloane JP; Ponder BA; Shearer RJ
Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
[TBL] [Abstract][Full Text] [Related]
6. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma.
Loy TS; Alexander CJ; Calaluce RD
Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688
[TBL] [Abstract][Full Text] [Related]
7. Expression of Leu-M1 antigens in carcinoma of the urinary bladder.
Hoshi S; Orikasa S; Numata I; Nose M
J Urol; 1986 May; 135(5):1075-7. PubMed ID: 3083124
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
[TBL] [Abstract][Full Text] [Related]
9. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
10. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
Fradet Y; Cordon-Cardo C; Whitmore WF; Melamed MR; Old LJ
Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
[TBL] [Abstract][Full Text] [Related]
12. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
13. Cellular heterogeneity in normal and neoplastic human urothelium: a study using murine monoclonal antibodies.
Dotsikas G; Konowalchuk T; Major PP; Kovac PE; Ward GK; Stewart SS; Price GB; Elhilali MM; Mackillop WJ
Br J Cancer; 1987 Oct; 56(4):439-44. PubMed ID: 3689660
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72.
Clemo FA; DeNicola DB; Carlton WW; Walker E; Morrison WB
Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody to human transitional cell carcinoma of the bladder: production and characterization.
Takahashi N; Takahashi S; Takahashi K; Suzuki T; Funyu T
J Urol; 1987 Jul; 138(1):207-11. PubMed ID: 2439711
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen in normal urothelium and urothelial lesions of the urinary bladder: a quantitative assessment using a true color image analysis system.
Knuechel R; Burgau M; Rueschoff J; Hofstaedter F
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(3):137-44. PubMed ID: 7902171
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
18. T-antigen in normal and neoplastic urothelium.
Limas C; Lange P
Cancer; 1986 Sep; 58(6):1236-45. PubMed ID: 3742450
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of human carcinoma-associated antigen in urothelial carcinoma of the bladder.
Yao JL; Bourne PA; Yang Q; Lei J; di Sant'Agnese PA; Huang J
Arch Pathol Lab Med; 2004 Jul; 128(7):785-7. PubMed ID: 15214822
[TBL] [Abstract][Full Text] [Related]
20. Plasma membrane-associated antigens on tumor cells derived from transitional-cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens.
Schneider MU; Paulie S; Troye M; Perlmann P
Int J Cancer; 1980 Aug; 26(2):193-202. PubMed ID: 7203713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
